Results · Apr-Jun 2026 · filed 8 Aug 2026
Advanced Enzyme Technologies Q1 FY27 results
Sales grew 2% to ₹190 crore from ₹186 crore in Apr-Jun 2025.
Operating profit fell 10% to ₹51 crore, an operating margin of 26.9% (down 3.5 points from a year ago).
Net profit fell 5% to ₹38.6 crore from ₹40.4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −7%, net profit −15%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 189.8 | 185.9 | +2% |
| Operating profit (EBITDA) | 51.0 | 56.4 | −10% |
| Operating margin | 26.9% | 30.4% | −3.5 pts |
| Net profit | 38.6 | 40.4 | −5% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Advanced Enzyme reported Apr–Jun 2026 revenue of ₹190 crore, up 2% from a year earlier but down 7% from the previous quarter, with EBITDA margin declining to 27% from 30% due to higher energy costs & a ₹10 crore revenue reversal. Management expects double-digit growth for the full year & 30% EBITDA margin recovery.
The last 7 quarters
Filings that week
- 12 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 11 Aug 2026Corporate Action-Updates on Buy back
- 11 Aug 2026Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
- 10 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 8 Aug 2026Corporate Action-Buy back
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Acquisition
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.